COVID-19

Outside of the loss of human life due to the COVID-19 pandemic, the past two years have greatly affected hospitals, health systems and the way providers deliver care. Healthcare executives are grappling with federal monetary assistance, growing burnout rates, workforce shortages and federal oversight of vaccines and testing. This channel is also designed to update clinicians on new research and guidelines regarding COVID patient treatment strategies and risk assessments.

PET imaging reveals long-term heart and lung damage from COVID-19
New data highlight the long-lasting effects of the coronavirus, revealing changes that are not detectable by standard medical assessments.
HHS, NIH announce new ‘universal’ vaccine standard for broad-spectrum protection
Currently in development, the “Generation Gold Standard” platform utilizes inert whole viruses to combat more strains of common illnesses, such as COVID and the flu. It’s on track for FDA approval in 2029.
HHS sued over RFK’s $11B cuts to infectious disease control
The Department of Health and Human Services is refusing to allocate funds meant to support state and local healthcare initiatives, as the money stemmed from now-defunct COVID-19 control efforts. A coalition of municipalities is suing to lift the block.
Owner of home healthcare company gets 14 months for defrauding COVID programs
Nakita Cannady, 49, was also convicted of defrauding Cigna to the tune of $194,000, billing the insurer for patient care hours her providers never filled.
Deaths after TAVR are on the rise: Is the pandemic to blame or should cardiologists be concerned?
COVID-19 may help explain the increased rates of cardiac and noncardiac mortality among TAVR patients, but there are several other factors to consider as well. Researchers explored nearly 11 years of STS/ACC registry data to learn more.

STEMI patients with COVID-19 face an elevated risk of death

The new study, published in JAMA, examined patients presenting with both in-hospital and out-of-hospital STEMI.

FDA authorizes Pfizer COVID-19 vaccine for children 5 to 11

The administration said it studied the vaccine's safety in more than 3,100 children, and no serious side effects have been reported thus far.

No signs of heart damage after COVID-19 vaccination among younger children

Pfizer shared detailed clinical trial results with the FDA that highlight the effectiveness of its reduced-dose COVID-19 vaccine for children between the ages of 5 and 11.

Statin use may increase the risk of severe illness among COVID-19 patients

The new analysis emphasized, however, that COVID-19 mortality did not appear to be affected by prior statin use.

Small cash incentives kept vaccination rates from nosediving, pilot study shows

More than 40% surveyed said the cash card played an important role in their decision, experts explained in JAMA Internal Medicine.

American Heart Association supports latest COVID-19 vaccine recommendations, including 'mixing and matching' of booster shots

The group says it also still supports wearing masks when indoors and practicing social distancing.

The exact effect of statin use on COVID-19 outcomes remains unclear

Researchers examined data from nearly 470,000 patients.

Scenes from the pandemic: Telehealth a perfect fit for treating heart failure

One large health system actually treated more heart failure patients during the pandemic than it had in previous years.

COVID-19

PET imaging reveals long-term heart and lung damage from COVID-19

HHS, NIH announce new ‘universal’ vaccine standard for broad-spectrum protection

HHS sued over RFK’s $11B cuts to infectious disease control

Owner of home healthcare company gets 14 months for defrauding COVID programs

Deaths after TAVR are on the rise: Is the pandemic to blame or should cardiologists be concerned?